BFNHOTCLaboratory Analytical InstrumentsFiscal year ends December 31

BIOFORCE NANOSCIENCES HOLDINGS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$6.87−0.04 (-0.58%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

Bioforce Nanosciences has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Announcements Bioforce Nanosciences filed with the SEC

Aug 18, 2026, 2:02 PM ET
RYDER SCOTT PETROLEUM AND GEOLOGICAL ENGINEERING REPORT
Regulation FD disclosure · EX-99.01 to Form 8-K
Aug 18, 2026, 2:02 PM ET
CONSENT LETTER - RYDER SCOTT
Regulation FD disclosure · EX-99.02 to Form 8-K
Jul 7, 2026, 1:04 PM ET
EX-99.01 to Form 8-K
Other events · EX-99.01 to Form 8-K
Jun 18, 2026, 8:28 AM ET
EX-99.1 to Form 8-K
Executive or director change · Other events · EX-99.1 to Form 8-K
Jun 18, 2026, 8:28 AM ET
EX-99.2 to Form 8-K
Executive or director change · Other events · EX-99.2 to Form 8-K
Jun 18, 2026, 8:28 AM ET
EX-99.3 to Form 8-K
Executive or director change · Other events · EX-99.3 to Form 8-K